PhRMA reports lists 547 neurological drugs in development

The therapy is now the first and only FDA-approved treatment that maintains vision with fewer treatments compared to standard-of-care injections.

Don Arthur, RPh, discusses what lays ahead in independent pharmacy, from clinical care to success stories.

The approval makes Johnson and Johnson’s esketamine nasal spray the first and only monotherapy for the treatment of major depressive disorder in adult patients.

Learn more about the ins and outs of pharmacy ownership from the experts at First Financial Bank.

Zepbound from Eli Lilly is the first and only prescription medicine approved by the FDA for adults with obstructive sleep apnea and obesity.

The patient’s symptoms gradually resolved after discontinuing fezolinetant therapy.